Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Laboratory Powder X-ray Diffraction System used for Pharmaceutical Challenges – page properties

Pharmaceutical Challenges Aided by a Laboratory Powder X-ray Diffraction (PXRD) System

Abstract

This document explores a number of ways that today’s modern, laboratory-based PXRD instrumentation and advanced software can greatly assist pharmaceutical scientists in their quest to develop high quality, stable products and accelerate their speed to market. All applications described and many more can be performed on a single PXRD instrument.

Detecting the Presence of Trace Polymorphs and Impurities

In the pharmaceutical industry, the detection of polymorph traces is one of the most important applications for powder X-ray diffraction. The need for better limits of detection (LOD) is driving advances in detector and optical technologies. While classical PXRD con gurations were purported to have a limit of detection (LOD) in the range of 0.5-2%,1,2,3 modern systems with specially designed optics can have detection limits below 0.1%, up to an order of magnitude below the commonly believed detection limit. These optics achieve excellent LOD by suppressing the continuous radiation (Bremsstrahlung) and therefore improving the signal to noise ratio in the data.

Enjoy our FREE content!

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login if you already created an account

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login as a Guest or via Social Media

Related White Papers

Effective Removal of mAb Aggregate Using Ca++Pure-HA® Media with Potassium Salts

| Contributed by Tosoh

Protein stability analysis technologies for the biopharmaceutical industry

| Contributed by Malvern Panalytical

Technology for combating counterfeit medicine

| Contributed by Malvern Panalytical

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Related Articles

Business & Regulation

What it Takes to Bloom

| James Strachan

Discovery & Development

Advancing Therapies

| James Strachan

Business & Regulation

News-in-Brief

| James Strachan

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker